Comment on Anticonvulsants and suicide attempts in bipolar type I disorders

Acta Psychiatrica Scandinavica

Volumn 136, Issue 1, 2017, Pages 141-

  de Toffol, B ^a  

^a CHRU de Tours   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

BIPOLAR I DISORDER; BIPOLAR MANIA; DRUG RESISTANT EPILEPSY; DRUG SENSITIVITY; FOOD AND DRUG ADMINISTRATION; HUMAN; LETTER; MIXED MANIA AND DEPRESSION; NEUROLOGIST; PRIORITY JOURNAL; RISK FACTOR; SEIZURE; SUICIDE ATTEMPT; BIPOLAR DISORDER; SUICIDE;

ANTICONVULSANTS; BIPOLAR DISORDER; HUMANS; SUICIDE; SUICIDE, ATTEMPTED;

EID: 85019914286     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12751     Document Type: Letter

References (5)

1. Bellivier F, Belzeaux R, Scott J, Courtet P, Golmard JL, Azorin JM. Anticonvulsants and suicide attempts in bipolar type I disorders. Acta Psychiatr Scand 2017;135:470–478.
2. Hesdorffer DC, Ishihara L, Mynepalli L, Webb DJ, Weil J, Hauser WA. Epilepsy, suicidality and psychiatric disorders: A bidirectional association. Ann Neurol 2012;72:184–191.
3. Ettinger AB, Reed ML, Goldberg JF, Hirschfeld RM. Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders. Neurology 2005;65:535–540.
4. Kanner AM. Management of psychiatric and neurological comorbidities in epilepsy. Nature Rev 2016;12:106–116.
5. Keezer MR, Sisodiya SM, Sander JW. Comorbidities of epilepsy: current concepts and future perspectives. Lancet Neurol 2016;15:106–115.